Skip to main content

RT @RichardPAConway: Papagoras et al. Serum GM-CSF increased in AxSpA and persists despite TNFi. Are we going to have a

Social Author Name
Richard Conway
Tweet Content
Papagoras et al. Serum GM-CSF increased in AxSpA and persists despite TNFi. Are we going to have a trial of mavrilimumab in AxSpA then? @RheumNow #ACR22 Abstr#1156 https://t.co/wCFsY9nC1p https://t.co/lrQQ7tIX4x
Show on Archive Page
On
Display in Search Results
On
PDQ
Off